NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia

Rhea-AI Summary

Tikvah Management LLC, owning 1.5% of Quanterix Corp (QTRX) shares, has announced its intention to vote against the proposed merger with Akoya Biosciences (AKYA) at the upcoming Special Meeting. As a significant investor since 2018, Tikvah argues that the merger undervalues Quanterix shares and would significantly reduce the company's cash runway post-merger. The investment firm also supports other investors' opposition, emphasizing that Quanterix's business is superior to Akoya's. Tikvah maintains the right to modify its position if significant developments arise.

Positive

• Quanterix's business is considered superior to Akoya's
• Significant shareholders actively engaging in protecting shareholder value
• Company maintains flexibility to consider better strategic alternatives

Negative

• Proposed merger could potentially undervalue Quanterix shares
• Merger would significantly reduce company's cash runway
• Growing shareholder opposition could create uncertainty about the company's strategic direction

CHARLOTTE, N.C.--(BUSINESS WIRE)-- Tikvah Management LLC (together with its affiliates, “Tikvah” or “we”), which owns approximately 1.5% of the outstanding common shares of Quanterix Corp. (Nasdaq: QTRX) (“Quanterix” or the “Company”), today announced that it intends to vote AGAINST the Company’s proposed merger with Akoya Biosciences, Inc. (“Akoya”) (Nasdaq: AKYA) at the upcoming Quanterix Special Meeting of shareholders. As a significant investor in the Company since 2018, Tikvah believes the proposed merger is not in the best interest of Quanterix’s shareholders. Tikvah echoes the public comments made by other investors opposing the merger, including that the proposed transaction undervalues Quanterix’s shares, there would be a significant reduction in the Company’s cash runway post-merger, and that Quanterix’s business is far superior to Akoya’s.

Tikvah reserves the right to change this intention should there be significant new developments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250324019163/en/

Media Contact:

Josh Kuckley

980 433 1057

jk@simcah.com

Source: Tikvah Management LLC

FAQ

Why is Tikvah Management voting against the Quanterix-Akoya merger?

Tikvah Management is voting against the merger because they believe it undervalues Quanterix shares, would reduce the company's cash runway post-merger, and considers Quanterix's business superior to Akoya's.

What percentage of Quanterix (QTRX) shares does Tikvah Management own?

Tikvah Management owns approximately 1.5% of Quanterix's outstanding common shares.

What are the main concerns about the Quanterix-Akoya merger in 2025?

The main concerns include undervaluation of Quanterix shares, significant reduction in cash runway post-merger, and the belief that Quanterix's business is superior to Akoya's.

Can Tikvah Management change its voting decision on the QTRX-AKYA merger?

Yes, Tikvah Management has reserved the right to change its voting intention if there are significant new developments.